Doctors’ soaring use of AI scribes prompts Australian government warning over privacy

The federal health department has said AI scribes used by doctors ‘have little oversight’ and raised concerns about the use of the tools in healthcare settings. Photograph: Brian Jackson/Alamy View image in fullscreen The federal health department has said AI scribes used by doctors ‘have little oversight’ and raised concerns about the use of the tools in healthcare settings. Photograph: Brian Jackson/Alamy Doctors’ soaring use of AI scribes prompts Australian government warning over privacy Exclusive: With the technology fast becoming popular in GP surgeries, regulators are monitoring its implementation and potential pitfalls Get our breaking news email , free app or daily news podcast The federal health department has raised concerns about the use of AI scribes by doctors as the health regulator considers the need for safeguards around the technology. AI scribe tools record, transcribe and summarise conversations between doctors and patients for medical notes, and have boomed in popularity in the past 18 months. According to an online poll by the Royal Australian College of General Practitioners (RACGP), use of AI scribes by doctors in Australia nearly doubled from 22% in August 2024 to 40% in November 2025. Two in five Australian GPs use AI scribes to record patient notes – but do they trade care for convenience? Read more Companies offering the technology to practitioners say it has been used hundreds of millions of times across the globe in the past 18 months alone as doctors seek to ease the administrative burden of patient consultations. The federal health department has identified concerns about the growing use of the technology. In February 2026 Senate estimates briefing documents, obtained by Guardian Australia under freedom of information laws, the department noted AI scribes “have little oversight” and raised concerns about the use of such tools in healthcare settings. Digital scribes are classified as “medical devices” – and therefore regulated by the Therapeutic Goods Act – only if they serve a therapeutic purpose. “Anecdotally, some are marketed as outside regulatory levers (e.g., not a medical device) or as privacy‑compliant, often with limited transparency,” the department said. “Some suppliers may be unaware their cloud platforms send data outside Australia, raising risks for patient data security.” The department said some suppliers advertised a 30% revenue increase for health professionals with no additional hours or patient consultations, “which has implications for [Medicare Benefits Scheme] costs”. Sign up for the Breaking News Australia email In an April briefing document from the department’s AI advisory group, it was noted that AI scribes could improve clinicians’ productivity and potentially reduce their burnout, but were subject to the same limitations as other large language models in terms of quality and accuracy. “This has implications for patient safety, clinical accountability, and the integrity of data held withi